All news

Truist lifts HCA target to $510, sees 9% upside

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Truist Securities has reiterated its "Buy" rating for HCA Healthcare and increased its price target to $510 from $495, representing a 3.0% raise. This new price target suggests a 9.0% upside from HCA's closing price of $467.73 on November 2nd. Other recent analyst actions on HCA Healthcare have seen price targets ranging from $401 to $521 over the past 30 days.

Read original source

HCA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.